ICU Medical Inc. (ICUI)
NASDAQ: ICUI
· Real-Time Price · USD
121.01
9.11 (8.14%)
At close: Aug 15, 2025, 3:59 PM
120.95
-0.05%
After-hours: Aug 15, 2025, 07:18 PM EDT
ICU Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 548.87M | 604.7M | 629.8M | 589.13M | 596.46M | 565.96M | 587.99M | 553.31M | 549.31M | 568.65M | 578.01M | 597.86M | 561M | 543.12M | 340.52M | 336.06M | 321.68M | 318.05M |
Cost of Revenue | 340.8M | 394.59M | 402.55M | 384.28M | 389.03M | 382.69M | 430.19M | 369.39M | 356.98M | 376.61M | 403.07M | 411.46M | 393.41M | 374.3M | 213.03M | 208.27M | 198.15M | 205.37M |
Gross Profit | 208.06M | 210.11M | 227.26M | 204.85M | 207.43M | 183.26M | 157.8M | 183.92M | 192.33M | 192.04M | 174.94M | 186.4M | 167.59M | 168.83M | 127.49M | 127.79M | 123.53M | 112.68M |
Operating Income | 10.59M | 12.89M | 37.69M | 8.24M | 7.69M | -10.65M | -12.18M | 22.85M | 2.76M | 19.44M | -49.4M | 10.15M | -48K | -7.25M | 23.82M | 38.38M | 34.47M | 26.57M |
Interest Income | 2.52M | 3.23M | 2.73M | 2.6M | 2.81M | 2.65M | 2.3M | 1.75M | 1.71M | 1.75M | n/a | 3.34M | 833K | 589K | n/a | 700K | 700K | 700K |
Pretax Income | 33.68M | -10.91M | 8.22M | -17.93M | -19.53M | -36.77M | -36.68M | -5.37M | -22.86M | -13.39M | -21.45M | -21.31M | -16.85M | -54.8M | 23.34M | 37.92M | 34.83M | 27.09M |
Net Income | 35.34M | -15.48M | -23.83M | -32.98M | -21.41M | -39.47M | -17.15M | 7.24M | -9.93M | -9.81M | -15.54M | -13.21M | -7.47M | -38.07M | 19.93M | 31.08M | 28.4M | 23.73M |
Selling & General & Admin | 159.39M | 157.23M | 158.85M | 162.71M | 159.55M | 157.66M | 154.62M | 148.61M | 150.9M | 152.57M | 142.93M | 153.45M | 158.75M | 153.21M | 81.46M | 74.81M | 73.92M | 72.39M |
Research & Development | 21.87M | 23.29M | 22.36M | 21.03M | 23.39M | 21.84M | 22.41M | 20.87M | 22.3M | 19.76M | 23.45M | 23.11M | 22.56M | 23.87M | 13.17M | 12.24M | 11.38M | 10.71M |
Other Expenses | 16.22M | 16.7M | 8.36M | 12.88M | 16.8M | n/a | 6.74M | -8.41M | -1.5M | -269K | -1.15M | 311K | n/a | 1M | -122K | -287K | 200K | 200K |
Operating Expenses | 197.48M | 197.22M | 189.57M | 196.62M | 199.74M | 179.5M | 183.77M | 161.07M | 173.2M | 172.33M | 166.38M | 176.56M | 181.31M | 177.08M | 94.62M | 87.05M | 85.31M | 83.23M |
Interest Expense | 23.07M | 29.02M | 26.19M | 27.29M | 26.65M | 26.42M | 26.71M | 25.92M | 25.83M | 24.27M | 20.07M | 21.15M | 16.27M | 13.64M | 366K | 168K | 163K | 161K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 538.28M | 591.81M | 592.11M | 580.89M | 588.76M | 577.31M | 600.04M | 530.46M | 530.18M | 548.94M | 569.45M | 588.02M | 574.72M | 551.38M | 307.66M | 295.32M | 283.45M | 288.59M |
Income Tax Expense | 1.18M | -4.57M | 32.05M | 15.05M | 1.87M | 2.7M | -19.53M | -12.6M | -12.93M | -3.58M | -5.91M | -8.1M | -9.38M | -16.73M | 3.41M | 6.84M | 6.43M | 3.36M |
Shares Outstanding (Basic) | 24.64M | 24.54M | 24.49M | 24.44M | 24.39M | 24.22M | 24.14M | 24.13M | 24.07M | 24.01M | 23.99M | 23.91M | 23.9M | 23.64M | 21.26M | 21.21M | 21.2M | 21.15M |
Shares Outstanding (Diluted) | 24.71M | 24.54M | 24.49M | 24.44M | 24.39M | 24.22M | 24.14M | 24.37M | 24.07M | 24.01M | 23.99M | 23.91M | 23.9M | 23.65M | 21.81M | 21.73M | 21.7M | 21.7M |
EPS (Basic) | 1.43 | -0.63 | -0.97 | -1.35 | -0.88 | -1.63 | -0.71 | 0.30 | -0.41 | -0.41 | -0.65 | -0.55 | -0.31 | -1.61 | 0.94 | 1.47 | 1.34 | 1.12 |
EPS (Diluted) | 1.43 | -0.63 | -0.97 | -1.35 | -0.88 | -1.63 | -0.71 | 0.30 | -0.41 | -0.41 | -0.65 | -0.55 | -0.31 | -1.61 | 0.91 | 1.43 | 1.31 | 1.09 |
EBITDA | 106.41M | 67.56M | 87.42M | 64.96M | 69.72M | 53.14M | 51.72M | 285.49M | 73.55M | 79.66M | 66.9M | 58.48M | 71.52M | 17.27M | 49.27M | 62.71M | 59.53M | 51.78M |
EBIT | 56.74M | 18.11M | 34.41M | 9.36M | -848K | -2.39M | -16.17M | 11.74M | 10.6M | 18.26M | -1.71M | -156K | -581K | -41.16M | 23.7M | 38.12M | 35.03M | 27.25M |
Depreciation & Amortization | 49.66M | 49.45M | 52.99M | 55.6M | 55.32M | 55.53M | 57.16M | 273.75M | 62.95M | 61.4M | 63.08M | 65.14M | 72.1M | 58.42M | 25.56M | 24.59M | 24.51M | 24.53M |